Examining the Feasibility and Utility of Estimating Partial Expected Value of Perfect Information (via a Nonparametric Approach) as Part of the Reimbursement Decision-Making Process in Ireland: Application to Drugs for Cancer
Crossref DOI link: https://doi.org/10.1007/s40273-017-0552-y
Published Online: 2017-08-02
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McCullagh, Laura http://orcid.org/0000-0001-8342-8739
Schmitz, Susanne
Barry, Michael
Walsh, Cathal
Funding for this research was provided by:
Health Research Board (RL2013/04 Research Leader Award)
License valid from 2017-08-02